Author

Abeer Butt

Institution: Washington University in St. Louis

Observed institution: Washington University in St. Louis

OpenAlex ID: A5058734619

The Combination of Duvelisib, a PI3K-δ,γ Inhibitor, and Romidepsin Is Highly Active in Relapsed/Refractory Peripheral T-Cell Lymphoma with Low Rates of Transaminitis: Results of Parallel Multicenter, Phase 1 Combination Studies with Expansion Cohorts

2018 · Steven M. Horwitz, Alison J. Moskowitz, et al. · Blood · 40

Ctim-23. a Phase Ii Study of Retifanlimab (pd-1 Inhibitor) and Epacadostat (ido1 Inhibitor) in Combination With Bevacizumab and Hypofractionated Radiotherapy for Recurrent Glioblastoma: Nct03532295

2024 · Abeer Butt, Jingqin Luo, et al. · Neuro-Oncology

Works count: 2

Citation count: 40

H-index: 1

I10-index: 1